All the news from the last week of August 2015.
Catch up with our weekly commercialisation news roundup.
Coursera plots out $60m series C
The open access education company has raised $49m of a $60m round and formed a partnership with new investor Times Internet to help it break the Indian market.
Oncology company Mirna seeks $80.5m from IPO
The cancer treatment developer has raised $94m in equity and grant funding, with Pfizer, Celgene and Baxter among its shareholders.
FluGen gets a $12m shot in the arm
Wisconsin-Madison spinout FluGen secures $12m series A for universal influenza vaccine.
Florida’s Orange County provides $100,000 for evergreen fund also backed by Central Florida University.
Immatics US launches with $40m
Immatics Biotechnologies has teamed up with University of Texas MD Anderson Cancer Center to set up Immatics US and develop treatments for tumours.
Leute gives Osage the Stanford touch
Osage University Partners hires former Stanford Office of Technology Licensing associate director Kirsten Leute for university relations post.
Undagrid takes flight with Delft
Delft University of Technology one of consortium backing IoT startup Undagrid.
OrganoClick points to strong growth post IPO
Stockholm spinout OrganoClick reports 44% sales increase following its Nasdaq float earlier in the year.
University Ventures’ fund intrigue
Editor-in-chief James Mawson speculates on University Ventures second fund, raised last week and securing $31m more than its first.
Memphis looks to sow its seeds
Memphis’ Crews Centre for Entrepreneurship launches seed fund to back the university’s spinouts.
Hatteras on the way to fifth fund
Hatteras Venture Partners raises $90m of its $150m target on fifth fund with backing from Chapel Hill.
Catch up with the week’s past university commercialisation news.
